Drug allergy epidemiology and demographics: Difference between revisions
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} {{AE}} {{CP}} | {{CMG}} {{AE}} {{CP}} | ||
{{Drug allergy}} | {{Drug allergy}} | ||
Line 8: | Line 8: | ||
Adverse drug reactions may occur in up to 10% of the worldwide population, and also affect up to 20% of patients who are hospitalized. | Adverse drug reactions may occur in up to 10% of the worldwide population, and also affect up to 20% of patients who are hospitalized. | ||
Of all the cases of fatalities caused by anaphylaxis, drugs may be responsible for 20% of the deaths. The incidence of toxic epidermal necrolysis is about 0.4-1.2 cases per million in a year. | Of all the cases of fatalities caused by anaphylaxis, drugs may be responsible for 20% of the deaths. The incidence of toxic epidermal necrolysis is about 0.4-1.2 cases per million in a year. | ||
Immediate hypersensitivity are over-reported and few patient reporting these have reactions on careful testing.<ref>{{Cite journal | |||
| doi = 10.1016/j.jaip.2013.02.002 | |||
| issn = 2213-2198 | |||
| volume = 1 | |||
| issue = 3 | |||
| pages = 258-263 | |||
| last = Macy | |||
| first = Eric | |||
| coauthors = Eunis W. Ngor | |||
| title = Safely Diagnosing Clinically Significant Penicillin Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin | |||
| journal = The Journal of Allergy and Clinical Immunology: In Practice | |||
| accessdate = 2013-07-13 | |||
| date = 2013-05 | |||
| url = http://www.sciencedirect.com/science/article/pii/S2213219813001232 | |||
}}</ref><ref name="pmid15197017">{{cite journal| author=Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P| title=Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. | journal=Ann Intern Med | year= 2004 | volume= 140 | issue= 12 | pages= 1001-6 | pmid=15197017 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15197017 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Allergology]] | |||
[[Category:Immunology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Needs content]] | |||
{{WH}} | |||
{{WS}} |
Latest revision as of 09:35, 13 July 2013
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
Drug Allergy |
Diagnosis |
---|
Treatment |
Case Studies |
Drug allergy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Drug allergy epidemiology and demographics |
Risk calculators and risk factors for Drug allergy epidemiology and demographics |
Overview
Adverse drug reactions may occur in up to 10% of the worldwide population, and also affect up to 20% of patients who are hospitalized. Of all the cases of fatalities caused by anaphylaxis, drugs may be responsible for 20% of the deaths. The incidence of toxic epidermal necrolysis is about 0.4-1.2 cases per million in a year.
Immediate hypersensitivity are over-reported and few patient reporting these have reactions on careful testing.[1][2]
References
- ↑ Macy, Eric (2013-05). "Safely Diagnosing Clinically Significant Penicillin Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin". The Journal of Allergy and Clinical Immunology: In Practice. 1 (3): 258–263. doi:10.1016/j.jaip.2013.02.002. ISSN 2213-2198. Retrieved 2013-07-13. Unknown parameter
|coauthors=
ignored (help); Check date values in:|date=
(help) - ↑ Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P (2004). "Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction". Ann Intern Med. 140 (12): 1001–6. PMID 15197017.